( NASDAQ-NMS:AMRI )

News from AMRI A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 23, 2016, 08:00 ET AMRI CEO to Present at Jefferies 2016 Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


May 10, 2016, 10:28 ET AMRI Clarifies 2016 Revenue Guidance

AMRI (NASDAQ: AMRI) clarified its 2016 revenue guidance, following the company's first quarter earnings conference call held earlier this...


May 10, 2016, 07:35 ET AMRI Announces First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2016 and provided an update to its...


May 09, 2016, 08:00 ET AMRI Appoints Louis Yu, Ph.D., as Senior Vice President, Quality and Compliance

AMRI (NASDAQ: AMRI) today announced that it has hired Louis Yu, Ph.D., to fill the newly created position of senior vice president of quality and...


May 05, 2016, 07:33 ET AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business

- Enters definitive agreement to acquire Euticals for $358 million in stock, cash and a seller note - Positions AMRI as one of the...


Apr 28, 2016, 07:00 ET AMRI to Announce First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2016 financial results before the opening of the market on Tuesday, May 10,...


Mar 30, 2016, 07:11 ET AMRI Announces Filing of Annual Report on Form 10K

AMRI (NASDAQ: AMRI) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the...


Mar 14, 2016, 08:00 ET AMRI Wins Four Life Science Leader Awards

 AMRI (NASDAQ: AMRI) today announced that it has been recognized as a Life Science Leader CMO Leadership Award recipient in the categories of...


Mar 11, 2016, 16:47 ET AMRI Announces Extension to File Form 10K for 2015

AMRI (NASDAQ: AMRI) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late...


Feb 17, 2016, 07:30 ET AMRI Announces Fourth Quarter and Full Year 2015 Results and Provides 2016 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an...


Feb 17, 2016, 07:15 ET AMRI Appoints David H. Deming and Kenneth P. Hagen to Board of Directors

 AMRI (NASDAQ: AMRI) today announced the appointment of David H. Deming, Managing Partner, TAG Healthcare Advisors, and Kenneth P. Hagen,...


Feb 09, 2016, 08:00 ET AMRI to Announce Fourth Quarter and Full Year 2015 Results

 AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2015 financial results before the opening of the market on...


Feb 04, 2016, 16:05 ET AMRI Appoints Anthony J. Maddaluna to Board of Directors

 AMRI (NASDAQ: AMRI) today announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global...


Jan 20, 2016, 08:45 ET AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business

 AMRI (NASDAQ: AMRI) announced today that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016....


Jan 14, 2016, 08:00 ET AMRI and NYCNMR Form Collaborative Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with the New York Center for...


Jan 12, 2016, 07:00 ET AMRI Announces 3-Year Extension of Insourcing Contract

 AMRI (NASDAQ: AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to...


Jan 11, 2016, 06:45 ET AMRI Announces First Product Approval Out of its Massachusetts Aseptic Fill Finish Site

 AMRI (NASDAQ: AMRI) announced that Docetaxel Injection (non-alcohol formula) has been approved for commercial manufacture at its Burlington,...


Jan 10, 2016, 18:00 ET AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Jan 07, 2016, 11:03 ET AMRI and Icagen Ink Collaboration Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) and Icagen, Inc. announced today that they have signed a collaboration agreement to co-market...


Jan 04, 2016, 08:00 ET AMRI CEO to Present at the 34th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


Dec 15, 2015, 08:13 ET AMRI Acquires Whitehouse Laboratories

 AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding equity interests of Whitehouse Laboratories, a leading provider...


Dec 10, 2015, 08:00 ET AMRI and Multispan Ink Collaboration Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with biotechnology company...


Dec 07, 2015, 08:00 ET AMRI Launches its U.S. Integrated Drug Discovery Center

Albany Molecular Research Inc. (NASDAQ: AMRI) today introduces its new U.S.-based integrated drug discovery center in Buffalo, N.Y. Located on the...


Nov 13, 2015, 08:00 ET AMRI CEO to Present at Jefferies Autumn 2015 Global Healthcare Conference London

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Nov 05, 2015, 07:00 ET AMRI Announces Third Quarter 2015 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30 2015. Highlights: - Third...